Denali Total Liab vs Net Tangible Assets Analysis

DNLI Stock  USD 23.70  0.19  0.80%   
Denali Therapeutics financial indicator trend analysis is much more than just examining Denali Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Denali Therapeutics is a good investment. Please check the relationship between Denali Therapeutics Total Liab and its Net Tangible Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.

Total Liab vs Net Tangible Assets

Total Liab vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Denali Therapeutics Total Liab account and Net Tangible Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Denali Therapeutics' Total Liab and Net Tangible Assets is 0.8. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Denali Therapeutics, assuming nothing else is changed. The correlation between historical values of Denali Therapeutics' Total Liab and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Denali Therapeutics are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Total Liab i.e., Denali Therapeutics' Total Liab and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

0.8
Relationship DirectionPositive 
Relationship StrengthStrong

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from Denali Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Denali Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.The current Selling General Administrative is estimated to decrease to about 54.3 M. The current Tax Provision is estimated to decrease to -6,300
 2021 2022 2023 2024 (projected)
Interest Income4.6M14.8M51.5M54.1M
Net Interest Income4.6M14.8M45.0M47.3M

Denali Therapeutics fundamental ratios Correlations

0.910.750.990.490.960.89-0.75-0.790.430.850.640.70.640.980.650.920.50.930.930.940.90.790.770.980.66
0.910.770.910.210.910.88-0.53-0.890.570.670.490.760.530.910.590.870.280.890.90.960.790.840.660.910.59
0.750.770.69-0.040.670.67-0.41-0.670.310.520.720.610.860.670.40.690.040.680.810.740.830.540.470.680.43
0.990.910.690.460.980.88-0.71-0.820.50.820.610.740.580.970.710.930.450.940.920.950.820.810.830.980.72
0.490.21-0.040.460.440.38-0.760.01-0.250.720.09-0.090.070.540.220.360.970.290.270.290.510.20.330.530.22
0.960.910.670.980.440.87-0.69-0.810.510.790.560.740.560.960.570.940.450.940.930.950.80.80.760.960.57
0.890.880.670.880.380.87-0.5-0.810.480.670.570.670.530.870.640.940.450.880.90.910.80.890.770.870.64
-0.75-0.53-0.41-0.71-0.76-0.69-0.50.260.03-0.97-0.42-0.16-0.37-0.75-0.37-0.49-0.73-0.55-0.5-0.51-0.74-0.33-0.51-0.74-0.38
-0.79-0.89-0.67-0.820.01-0.81-0.810.26-0.83-0.46-0.45-0.95-0.41-0.78-0.59-0.84-0.04-0.93-0.85-0.9-0.59-0.94-0.62-0.78-0.6
0.430.570.310.5-0.250.510.480.03-0.830.170.340.89-0.030.40.410.53-0.220.720.540.580.190.80.350.410.4
0.850.670.520.820.720.790.67-0.97-0.460.170.50.350.40.850.460.640.720.720.640.650.830.550.580.850.47
0.640.490.720.610.090.560.57-0.42-0.450.340.50.530.670.470.50.630.10.60.720.560.640.460.580.470.51
0.70.760.610.74-0.090.740.67-0.16-0.950.890.350.530.390.660.520.79-0.070.880.810.820.490.850.540.670.54
0.640.530.860.580.070.560.53-0.37-0.41-0.030.40.670.390.560.350.620.080.480.710.590.710.260.510.560.38
0.980.910.670.970.540.960.87-0.75-0.780.40.850.470.660.560.620.890.550.90.880.930.860.780.741.00.63
0.650.590.40.710.220.570.64-0.37-0.590.410.460.50.520.350.620.60.120.610.580.660.410.60.890.621.0
0.920.870.690.930.360.940.94-0.49-0.840.530.640.630.790.620.890.60.40.920.970.960.790.850.770.90.61
0.50.280.040.450.970.450.45-0.73-0.04-0.220.720.1-0.070.080.550.120.40.310.320.330.590.260.240.550.12
0.930.890.680.940.290.940.88-0.55-0.930.720.720.60.880.480.90.610.920.310.920.930.760.930.710.910.62
0.930.90.810.920.270.930.9-0.5-0.850.540.640.720.810.710.880.580.970.320.920.960.840.820.720.880.59
0.940.960.740.950.290.950.91-0.51-0.90.580.650.560.820.590.930.660.960.330.930.960.780.860.760.930.67
0.90.790.830.820.510.80.8-0.74-0.590.190.830.640.490.710.860.410.790.590.760.840.780.620.50.860.42
0.790.840.540.810.20.80.89-0.33-0.940.80.550.460.850.260.780.60.850.260.930.820.860.620.630.790.61
0.770.660.470.830.330.760.77-0.51-0.620.350.580.580.540.510.740.890.770.240.710.720.760.50.630.740.89
0.980.910.680.980.530.960.87-0.74-0.780.410.850.470.670.561.00.620.90.550.910.880.930.860.790.740.63
0.660.590.430.720.220.570.64-0.38-0.60.40.470.510.540.380.631.00.610.120.620.590.670.420.610.890.63
Click cells to compare fundamentals

Denali Therapeutics Account Relationship Matchups

Denali Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets553.2M1.6B1.4B1.5B1.2B932.8M
Other Current Liab20.4M42.5M47.7M63.8M61.2M31.3M
Total Current Liabilities45.3M71.7M378.2M363.9M78.0M121.8M
Total Stockholder Equity394.9M1.2B962.3M1.0B1.0B712.9M
Other Liab44.1M317.9M5.1M858K986.7K937.4K
Net Tangible Assets394.9M1.2B962.3M1.0B1.2B612.3M
Property Plant And Equipment Net80.7M73.5M69.6M74.5M71.6M52.4M
Net Debt(10.6M)(443.0M)(234.9M)(157.7M)(74.9M)(78.6M)
Retained Earnings(425.6M)(354.4M)(645.0M)(971.0M)(1.1B)(1.1B)
Accounts Payable2.6M1.1M4.8M2.8M9.5M10.0M
Cash79.4M507.1M293.5M218.0M127.1M194.5M
Non Current Assets Total123.2M108.6M506.9M87.9M89.8M154.9M
Non Currrent Assets Other2.7M2.5M11.9M11.9M18.1M19.1M
Other Assets2.7M2.5M11.9M13.4M1.00.95
Cash And Short Term Investments415.4M1.5B865.4M1.3B1.0B757.9M
Common Stock Shares Outstanding95.6M112.7M121.5M125.5M137.4M86.7M
Liabilities And Stockholders Equity553.2M1.6B1.4B1.5B1.2B932.8M
Non Current Liabilities Total113.0M382.1M63.6M53.9M45.0M42.7M
Capital Surpluse774.2M818.8M1.5B1.6B1.8B1.9B
Other Current Assets14.7M20.3M30.6M26.8M26.2M17.6M
Other Stockholder Equity818.8M1.5B1.6B2.0B2.1B1.1B
Total Liab158.3M453.7M441.9M417.8M123.0M220.0M
Property Plant And Equipment Gross80.7M73.5M69.6M74.5M117.6M123.5M
Total Current Assets430.0M1.5B897.2M1.4B1.1B778.0M
Accumulated Other Comprehensive Income350K(245K)(2.5M)(6.9M)643K675.2K
Common Stock1.3M1.5M1.5M1.7M1.7M1.6M
Property Plant Equipment80.7M40.8M69.6M74.5M85.7M44.6M
Short Term Investments335.9M962.6M571.9M1.1B907.4M633.8M
Long Term Investments61.3M147.9M39.9M32.7M425.4M0.0
Non Current Liabilities Other467K471K379K382.1M435.9K414.1K
Net Invested Capital394.9M1.2B962.3M1.0B1.0B879.0M
Net Working Capital384.7M1.4B519.0M1.0B986.2M811.7M
Current Deferred Revenue18.7M23.5M320.3M290.1M(46.9M)(44.6M)
Capital Stock1.3M1.5M1.5M1.7M1.7M1.7M
Short Term Debt3.7M4.7M5.5M7.3M7.3M6.3M

Currently Active Assets on Macroaxis

When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.76)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.24)
Return On Equity
(0.35)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.